Clover Health Investments, Corp.
NASDAQ:CLOV
2.91 (USD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 356.243 | 346.455 | 505.439 | 482.066 | 513.628 | 527.775 | 898.791 | 856.817 | 846.7 | 874.379 | 432.036 | 427.163 | 412.472 | 200.325 | 166.233 | 169.069 | 172.081 | 165.505 | 100.549 | 118.384 | 117.905 | 117.905 |
| Cost of Revenue
| 248.347 | 265.162 | 447.985 | 418.959 | 436.954 | 472.49 | 893.645 | 839.799 | 858.786 | 861.722 | 441.931 | 436.422 | 458.521 | 214.432 | 179.928 | 144.846 | 119.366 | 146.328 | 0 | 0 | 0 | 0 |
| Gross Profit
| 107.896 | 81.293 | 57.454 | 63.107 | 76.674 | 55.285 | 5.146 | 17.018 | -12.086 | 12.657 | -9.895 | -9.259 | -46.049 | -14.107 | -13.695 | 24.223 | 52.715 | 19.177 | 100.549 | 118.384 | 117.905 | 117.905 |
| Gross Profit Ratio
| 0.303 | 0.235 | 0.114 | 0.131 | 0.149 | 0.105 | 0.006 | 0.02 | -0.014 | 0.014 | -0.023 | -0.022 | -0.112 | -0.07 | -0.082 | 0.143 | 0.306 | 0.116 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 99.923 | 103.792 | 109.929 | 102.314 | 104.87 | 129.422 | 124.349 | 117.974 | 117.531 | 126.788 | 114.08 | 119.113 | 107.795 | 104.63 | 54.563 | 46.475 | 40.695 | 49.967 | 24.228 | 19.69 | 22.953 | 22.953 |
| Selling & Marketing Expenses
| 55.499 | 59.223 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.058 | 17.171 | 26.349 | 26.349 |
| SG&A
| 99.923 | 103.792 | 109.929 | 102.314 | 104.87 | 129.422 | 124.349 | 117.974 | 117.531 | 126.788 | 114.08 | 119.113 | 107.795 | 104.63 | 54.563 | 46.475 | 40.695 | 49.967 | 49.286 | 36.861 | 49.302 | 49.302 |
| Other Expenses
| -100.253 | -104.11 | -110.603 | 421.221 | 437.565 | -1.531 | -12.04 | -27.041 | -118.117 | -26.831 | 62.815 | 20.881 | 28.018 | 0.351 | -168.894 | -0.634 | -11.15 | -4.16 | 0.018 | 0 | 0 | 0 |
| Operating Expenses
| 100.253 | 104.11 | 110.603 | 103.263 | 100.731 | 127.891 | 112.309 | 90.933 | 90.641 | 99.957 | 176.895 | 139.994 | 135.813 | 104.981 | 53.934 | 45.841 | 29.545 | 45.807 | 0.018 | 162.568 | 230.527 | 230.527 |
| Operating Income
| 7.187 | -22.703 | -65.66 | -41.469 | -28.807 | -72.606 | -107.163 | -73.915 | -102.727 | -87.3 | -186.79 | -149.253 | -181.862 | -119.088 | -67.629 | -21.618 | 23.17 | -26.63 | -0.018 | -30.853 | -44.286 | -44.286 |
| Operating Income Ratio
| 0.02 | -0.066 | -0.13 | -0.086 | -0.056 | -0.138 | -0.119 | -0.086 | -0.121 | -0.1 | -0.432 | -0.349 | -0.441 | -0.594 | -0.407 | -0.128 | 0.135 | -0.161 | -0 | -0.261 | -0.376 | -0.376 |
| Total Other Income Expenses Net
| 7.17 | -23.17 | -70.472 | -1.313 | -4.75 | -72.606 | 23.117 | -1.393 | -1.227 | 11.991 | -0.412 | 115.152 | -134.512 | 85.506 | 2.661 | 48.052 | -4.475 | 11.995 | -16.552 | -20.811 | -72.415 | -72.415 |
| Income Before Tax
| 7.17 | -23.17 | -70.472 | -41.469 | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 | -75.309 | -187.202 | -34.527 | -317.611 | -48.417 | -81.581 | 12.758 | 5.403 | -28.162 | -0.018 | -51.664 | -116.701 | -116.701 |
| Income Before Tax Ratio
| 0.02 | -0.067 | -0.139 | -0.086 | -0.056 | -0.138 | -0.094 | -0.088 | -0.123 | -0.086 | -0.433 | -0.081 | -0.77 | -0.242 | -0.491 | 0.075 | 0.031 | -0.17 | -0 | -0.436 | -0.99 | -0.99 |
| Income Tax Expense
| -45.311 | -0.82 | -65.66 | 0.597 | 0.007 | -72.606 | -22.415 | 0.98 | 0.408 | -12.394 | 0.412 | 0.426 | 1.237 | 14.835 | 16.613 | 13.676 | 13.292 | 13.527 | -78.671 | -20.811 | -72.415 | -72.415 |
| Net Income
| 7.408 | -19.17 | -70.472 | -41.469 | -28.814 | -72.606 | -61.631 | -76.288 | -104.362 | -62.915 | -187.202 | -34.527 | -317.611 | -48.417 | -81.581 | 12.758 | 5.403 | -28.162 | -0.018 | -51.664 | -116.701 | -116.701 |
| Net Income Ratio
| 0.021 | -0.055 | -0.139 | -0.086 | -0.056 | -0.138 | -0.069 | -0.089 | -0.123 | -0.072 | -0.433 | -0.081 | -0.77 | -0.242 | -0.491 | 0.075 | 0.031 | -0.17 | -0 | -0.436 | -0.99 | -0.99 |
| EPS
| 0.015 | -0.039 | -0.15 | -0.086 | -0.06 | -0.15 | -0.13 | -0.16 | -0.22 | -0.13 | -0.4 | -0.083 | -0.78 | -0.13 | -0.2 | 0.032 | 0.013 | -0.07 | 0 | -1.21 | -2.76 | -2.76 |
| EPS Diluted
| 0.015 | -0.039 | -0.15 | -0.086 | -0.06 | -0.15 | -0.13 | -0.16 | -0.22 | -0.13 | -0.4 | -0.083 | -0.78 | -0.13 | -0.2 | 0.032 | 0.013 | -0.07 | 0 | -1.21 | -2.76 | -2.76 |
| EBITDA
| 7.99 | -21.212 | -46.98 | -39.599 | -23.058 | -72.327 | -107.163 | -73.299 | -102.141 | -86.474 | -185.942 | -149.133 | -181.744 | -118.928 | -67.487 | -21.48 | 23.323 | -26.508 | -0.018 | -20.811 | -72.415 | -72.415 |
| EBITDA Ratio
| 0.022 | -0.061 | -0.093 | -0.082 | -0.045 | -0.137 | -0.119 | -0.086 | -0.121 | -0.099 | -0.43 | -0.349 | -0.441 | -0.594 | -0.406 | -0.127 | 0.136 | -0.16 | -0 | -0.176 | -0.614 | -0.614 |